Franklin Resources
TEVA icon

Franklin Resources’s Teva Pharmaceuticals TEVA Stock Holding History

Franklin Resources’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.1M Buy
732,290
+715,150
+4,172% +$23M 0.01% 951
2025
Q4 		$535K Buy
17,140
+65
+0.4% +$1.6K ﹤0.01% 2369
2025
Q3 		$345K Buy
17,075
+1,850
+12% +$32.5K ﹤0.01% 2602
2025
Q2 		$255K Buy
+15,225
New +$246K ﹤0.01% 2628
2025
Q1 		– Sell
-46,826
Closed -$1.03M – 3067
2024
Q4 		$1.03M Sell
46,826
-108,265
-70% -$1.97M ﹤0.01% 1981
2024
Q3 		$2.67M Buy
155,091
+90,920
+142% +$1.59M ﹤0.01% 1633
2024
Q2 		$1.04M Buy
+64,171
New +$988K ﹤0.01% 1913
2021
Q4 		– Sell
-12,289
Closed -$120K – 2555
2021
Q3 		$120K Sell
12,289
-7,691
-38% -$72K ﹤0.01% 2309
2021
Q2 		$198K Buy
19,980
+5,487
+38% +$58.1K ﹤0.01% 1852
2021
Q1 		$167K Sell
14,493
-162,181
-92% -$1.86M ﹤0.01% 1831
2020
Q4 		$1.71M Buy
176,674
+162,806
+1,174% +$1.56M ﹤0.01% 1321
2020
Q3 		$125K Buy
+13,868
New +$147K ﹤0.01% 1710
2020
Q1 		– Sell
-19,916,016
Closed -$195M – 1566
2019
Q4 		$195M Sell
19,916,016
-21,560,376
-52% -$192M 0.1% 236
2019
Q3 		$285M Sell
41,476,392
-20,166,739
-33% -$155M 0.16% 172
2019
Q2 		$569M Sell
61,643,131
-2,980,753
-5% -$35.9M 0.3% 91
2019
Q1 		$1.01B Sell
64,623,884
-1,483,372
-2% -$26.2M 0.54% 39
2018
Q4 		$1.02B Sell
66,107,256
-426,849
-0.6% -$8.75M 0.62% 32
2018
Q3 		$1.43B Sell
66,534,105
-5,690,773
-8% -$132M 0.71% 21
2018
Q2 		$1.76B Sell
72,224,878
-907,895
-1% -$18.5M 0.9% 12
2018
Q1 		$1.25B Sell
73,132,773
-6,355,366
-8% -$124M 0.63% 25
2017
Q4 		$1.51B Buy
79,488,139
+6,009,897
+8% +$90.4M 0.72% 17
2017
Q3 		$1.29B Buy
73,478,242
+6,681,345
+10% +$150M 0.63% 29
2017
Q2 		$2.22B Buy
66,796,897
+6,685,844
+11% +$207M 1.11% 8
2017
Q1 		$1.93B Buy
60,111,053
+3,475,750
+6% +$119M 0.98% 8
2016
Q4 		$2.05B Buy
56,635,303
+9,775,505
+21% +$390M 1.06% 8
2016
Q3 		$2.16B Buy
46,859,798
+5,648,249
+14% +$295M 1.13% 7
2016
Q2 		$2.07B Buy
41,211,549
+4,389,590
+12% +$234M 1.11% 8
2016
Q1 		$1.97B Sell
36,821,959
-4,140,536
-10% -$243M 1.05% 9
2015
Q4 		$2.69B Sell
40,962,495
-6,954,803
-15% -$430M 1.36% 3
2015
Q3 		$2.71B Sell
47,917,298
-2,204,102
-4% -$143M 1.34% 3
2015
Q2 		$2.96B Sell
50,121,400
-4,925,570
-9% -$304M 1.34% 3
2015
Q1 		$3.43B Buy
55,046,970
+219,468
+0.4% +$12.8M 1.55% 2
2014
Q4 		$3.15B Sell
54,827,502
-227,254
-0.4% -$12.7M 1.43% 4
2014
Q3 		$2.96B Buy
55,054,756
+72,794
+0.1% +$3.86M 1.35% 3
2014
Q2 		$2.88B Buy
54,981,962
+5,708,606
+12% +$292M 1.27% 4
2014
Q1 		$2.6B Buy
49,273,356
+6,179,870
+14% +$286M 1.23% 5
2013
Q4 		$1.73B Buy
43,093,486
+21,877,679
+103% +$861M 0.84% 16
2013
Q3 		$802M Buy
21,215,807
+3,057,576
+17% +$119M 0.43% 54
2013
Q2 		$712M Buy
+18,158,231
New +$707M 0.41% 58

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources's TEVA Position: Q1 2026 in Review

Franklin Resources increased its Teva Pharmaceuticals (TEVA) stake by 4,172% in Q1 2026, buying an estimated $23M and bringing the position to 732,290 shares worth $22.1M. The position accounts for 0.01% of the portfolio, ranked #951.

Franklin Resources first reported a position in TEVA in Q2 2013 and has held it in 39 quarters since. The position peaked at $3.43B in Q1 2015. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Franklin Resources held 732,290 shares of Teva Pharmaceuticals worth $22.1M as of Q1 2026.
  • Franklin Resources bought 715,150 Teva Pharmaceuticals shares in Q1 2026, an estimated $23M.
  • Teva Pharmaceuticals made up 0.01% of Franklin Resources's portfolio in Q1 2026, its #951 holding.
  • Franklin Resources first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 39 quarters since.
  • Franklin Resources's Teva Pharmaceuticals position peaked at $3.43B in Q1 2015.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.